Income Statement Tenet Healthcare Corporation

Equities

THC

US88033G4073

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 20:00:02 12/03/2026 GMT			5-day change	1st Jan Change
224.73 ^USD	-4.20%		-6.91%	+13.09%

03-10	Tenet Healthcare Corporation Presents at Barclays 28th Annual Global Healthcare Conference, Mar-10-2026 09:30 AM
02-17	Truist Securities Adjusts Tenet Healthcare PT to $270 From $240, Maintains Buy Rating	MT

207fe550fb1f9340d4c3c1d4559b.m7RSkdWE-aQlCf6V5WpDOF60o81XEDRxsH6d0vMCGPE.ydMb4ZjbwelBMY_nqw96FRHcwOAgWWcW802sl71aYYb44T7Ym9PM_AhLqw

Published financial data: TENET HEALTHCARE CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	19.48B	19.17B	20.55B	20.66B	21.31B
Total Revenues	19.48B	19.17B	20.55B	20.66B	21.31B
Cost of Goods Sold, Total	12.22B	12.13B	12.74B	12.46B	12.49B
Gross Profit	7.27B	7.05B	7.8B	8.21B	8.82B
Selling General & Admin Expenses, Total	412M	412M	418M	417M	410M
Depreciation & Amortization - (IS)	855M	841M	870M	818M	863M
Other Operating Expenses	3.44B	3.31B	3.73B	3.76B	3.77B
Other Operating Expenses, Total	4.71B	4.56B	5.02B	4.99B	5.04B
Operating Income	2.56B	2.48B	2.79B	3.22B	3.77B
Interest Expense, Total	-923M	-890M	-901M	-826M	-821M
Interest And Investment Income	-	-	-	-	-
Net Interest Expenses	-923M	-890M	-901M	-826M	-821M
Income (Loss) On Equity Invest.	218M	216M	228M	260M	264M
Other Non Operating Income (Expenses)	25M	19M	26M	134M	125M
EBT, Excl. Unusual Items	1.88B	1.83B	2.14B	2.79B	3.34B
Restructuring Charges	-57M	-118M	-79M	-56M	-44M
Merger & Related Restructuring Charges	-20M	-14M	-15M	-39M	-25M
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	445M	1M	23M	2.92B	-1M
Asset Writedown	-8M	-94M	-43M	-7M	-61M
Legal Settlements	-116M	-70M	-47M	-35M	-64M
Other Unusual Items	-238M	-191M	-364M	-317M	-345M
EBT, Incl. Unusual Items	1.89B	1.34B	1.62B	5.25B	2.8B
Income Tax Expense	411M	344M	306M	1.18B	433M
Earnings From Continuing Operations	1.48B	1B	1.31B	4.06B	2.37B
Earnings Of Discontinued Operations	-1M	1M	-	-	-
Net Income to Company	1.48B	1B	1.31B	4.06B	2.37B
Minority Interest	-562M	-590M	-700M	-864M	-960M
Net Income - (IS)	914M	411M	611M	3.2B	1.41B
Net Income to Common Incl Extra Items	914M	411M	611M	3.2B	1.41B
Net Income to Common Excl. Extra Items	915M	410M	611M	3.2B	1.41B
Per Share Items
Net EPS - Basic	8.56	3.84	6.01	33.02	15.61
Basic EPS - Continuing Operations	8.56	3.83	6.01	33.02	15.61
Basic Weighted Average Shares Outstanding	107M	107M	102M	96.9M	90.15M
Net EPS - Diluted	8.42	3.79	5.71	32.7	15.49
Diluted EPS - Continuing Operations	8.43	3.78	5.71	32.7	15.49
Diluted Weighted Average Shares Outstanding	109M	111M	105M	97.88M	90.83M
Normalized Basic EPS	5.75	5.18	6.28	9.05	12.51
Normalized Diluted EPS	5.66	5.01	6.09	8.96	12.41
Supplemental Items
EBITDA	3.42B	3.33B	3.66B	4.04B	4.64B
EBITA	2.75B	2.66B	2.96B	3.39B	3.94B
EBIT	2.56B	2.48B	2.79B	3.22B	3.77B
EBITDAR	3.83B	3.74B	4.08B	4.45B	5.04B
Effective Tax Rate - (Ratio)	21.77	25.6	18.92	22.56	15.46
Current Domestic Taxes	161M	135M	254M	1.29B	424M
Total Current Taxes	161M	135M	254M	1.29B	424M
Deferred Domestic Taxes	250M	209M	52M	-103M	9M
Total Deferred Taxes	250M	209M	52M	-103M	9M
Normalized Net Income	614M	554M	639M	877M	1.13B
Interest Capitalized	4M	8M	9M	8M	9M
Interest on Long-Term Debt	950M	864M	899M	866M	898M
Non-Cash Pension Expense	-6M	4M	25M	28M	28M
Supplemental Operating Expense Items
Net Rental Expense, Total	412M	412M	418M	417M	410M
Imputed Operating Lease Interest Expense	181M	179M	187M	182M	189M
Imputed Operating Lease Depreciation	231M	233M	231M	235M	221M
Stock-Based Comp., COGS (Total)	56M	56M	66M	67M	-
Stock-Based Comp., Other (Total)	-	-	-	-	104M
Total Stock-Based Compensation	56M	56M	66M	67M	104M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	2.36B	858M	1.23B	3.02B	2.88B
Total Cash And Short Term Investments	2.36B	858M	1.23B	3.02B	2.88B
Accounts Receivable, Total	3.37B	3.46B	3.4B	3.05B	3.25B
Other Receivables	-	577M	542M	555M	609M
Total Receivables	3.37B	4.04B	3.95B	3.61B	3.86B
Inventory	384M	405M	411M	346M	348M
Prepaid Expenses	-	400M	391M	368M	423M
Other Current Assets, Total	960M	279M	1.19B	340M	339M
Total Current Assets	7.08B	5.98B	7.17B	7.68B	7.85B
Gross Property Plant And Equipment	13.39B	13.79B	13.8B	12.9B	14.13B
Accumulated Depreciation	-5.96B	-6.2B	-6.48B	-5.81B	-6.68B
Net Property Plant And Equipment	7.43B	7.59B	7.32B	7.09B	7.45B
Long-term Investments	1.82B	1.8B	1.56B	1.53B	1.44B
Goodwill	9.26B	10.12B	10.31B	10.69B	11.2B
Other Intangibles, Total	1.5B	1.42B	1.37B	1.4B	1.35B
Accounts Receivable Long-Term	213M	197M	334M	274M	121M
Deferred Tax Assets Long-Term	65M	19M	77M	80M	84M
Deferred Charges Long-Term	23M	24M	-	-	-
Other Long-Term Assets, Total	201M	-	180M	194M	186M
Total Assets	27.58B	27.16B	28.31B	28.94B	29.68B
Liabilities
Accounts Payable, Total	1.3B	1.5B	1.41B	1.29B	1.36B
Accrued Expenses, Total	1.38B	1.27B	1.41B	1.31B	1.24B
Current Portion of Long-Term Debt	29M	46M	36M	38M	34M
Current Portion of Leases	307M	306M	288M	258M	259M
Current Income Taxes Payable	-	-	-	18M	-
Unearned Revenue Current, Total	959M	117M	-	80M	88M
Other Current Liabilities	1.14B	1.23B	1.62B	1.31B	1.48B
Total Current Liabilities	5.11B	4.48B	4.76B	4.31B	4.46B
Long-Term Debt	15.34B	14.77B	14.76B	12.69B	12.68B
Long-Term Leases	1.1B	1.21B	1.13B	1.34B	1.45B
Unearned Revenue Non Current	15M	13M	-	13M	13M
Pension & Other Post Retirement Benefits	421M	331M	335M	298M	245M
Deferred Tax Liability Non Current	36M	217M	326M	227M	240M
Other Non Current Liabilities	1.31B	1.53B	1.49B	1.51B	1.61B
Total Liabilities	23.32B	22.55B	22.8B	20.39B	20.7B
Common Stock, Total	8M	8M	8M	8M	8M
Additional Paid In Capital	4.88B	4.78B	4.83B	4.87B	4.91B
Retained Earnings	-1.21B	-803M	-192M	3.01B	4.42B
Treasury Stock	-2.41B	-2.66B	-2.86B	-3.54B	-4.94B
Comprehensive Income and Other	-233M	-181M	-181M	-180M	-181M
Total Common Equity	1.03B	1.14B	1.61B	4.17B	4.22B
Minority Interest	3.23B	3.47B	3.9B	4.38B	4.75B
Total Equity	4.26B	4.61B	5.51B	8.55B	8.97B
Total Liabilities And Equity	27.58B	27.16B	28.31B	28.94B	29.68B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	107M	102M	100M	95.12M	86.96M
ECS Total Common Shares Outstanding	107M	102M	99.95M	95.11M	86.95M
Book Value / Share	9.59	11.17	16.09	43.85	48.53
Tangible Book Value	-9.73B	-10.4B	-10.07B	-7.92B	-8.33B
Tangible Book Value Per Share	-90.77	-101.76	-100.72	-83.24	-95.75
Total Debt	16.77B	16.33B	16.21B	14.33B	14.43B
Net Debt	14.4B	15.47B	14.94B	11.26B	11.49B
Debt Equivalent of Unfunded Proj. Benefit Obligation	446M	354M	359M	322M	269M
Debt Equivalent Oper. Leases	3.3B	3.3B	3.34B	3.34B	3.28B
Minority Interest, Total (Incl. Fin. Div)	3.23B	3.47B	3.9B	4.38B	4.75B
Account Code - Inventory Valuation	3	-	3	3	3
Inventories - Others	384M	405M	411M	346M	348M
Land - (BS)	635M	661M	625M	539M	534M
Buildings, Total	6.65B	6.65B	6.69B	6.13B	6.67B
Machinery, Total	4.46B	4.75B	4.75B	4.4B	5.04B
Full Time Employees	76.84K	75.78K	78.81K	74.48K	77K
Part Time Employees	24.26K	26.62K	27.69K	23.52K	23K
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	914M	411M	611M	3.2B	1.41B
Depreciation & Amortization - CF	667M	669M	696M	646M	697M
Amortization of Goodwill and Intangible Assets - (CF)	188M	172M	174M	172M	166M
Depreciation & Amortization, Total	855M	841M	870M	818M	863M
Amortization of Deferred Charges, Total - (CF)	33M	33M	32M	26M	23M
(Gain) Loss From Sale Of Asset	-423M	-1M	-23M	-2.92B	1M
(Gain) Loss on Sale of Investments - (CF)	-	-117M	-29M	-4M	-4M
Asset Writedown & Restructuring Costs	-68M	12M	-17M	-90M	-16M
(Income) Loss On Equity Investments - (CF)	-10M	2M	-13M	-29M	-34M
Stock-Based Compensation (CF)	56M	56M	66M	67M	104M
Provision and Write-off of Bad Debts	-	-	-	-	-
Net Cash From Discontinued Operations	-	-1M	-	-	-
Other Operating Activities, Total	948M	990M	806M	839M	1.06B
Change In Accounts Receivable	-197M	-140M	-29M	245M	20M
Change In Inventories	-52M	-64M	-139M	-86M	-73M
Change In Accounts Payable	-584M	-898M	215M	-30M	209M
Change In Income Taxes	68M	-26M	10M	16M	-25M
Change in Other Net Operating Assets	28M	-15M	14M	-9M	9M
Cash from Operations	1.57B	1.08B	2.37B	2.05B	3.54B
Capital Expenditure	-658M	-762M	-751M	-931M	-1.01B
Cash Acquisitions	-1.22B	-234M	-224M	-571M	-308M
Divestitures	1.25B	210M	71M	4.98B	38M
Investment in Marketable and Equity Securities, Total	-77M	-16M	-54M	-31M	3M
Other Investing Activities, Total	-7M	-6M	-11M	-19M	2M
Cash from Investing	-714M	-808M	-969M	3.43B	-1.28B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	2.87B	2.02B	1.37B	23M	2.28B
Total Debt Issued	2.87B	2.02B	1.37B	23M	2.28B
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-3.22B	-2.85B	-1.54B	-2.24B	-2.37B
Total Debt Repaid	-3.22B	-2.85B	-1.54B	-2.24B	-2.37B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-	-250M	-200M	-672M	-1.44B
Other Financing Activities, Total	-587M	-703M	-663M	-793M	-868M
Cash from Financing	-936M	-1.78B	-1.04B	-3.68B	-2.4B
Net Change in Cash	-82M	-1.51B	370M	1.79B	-136M
Supplemental Items
Cash Interest Paid	937M	848M	882M	851M	865M
Cash Income Tax Paid (Refund)	92M	161M	243M	1.27B	450M
Levered Free Cash Flow	1.56B	104M	893M	2.33B	1.68B
Unlevered Free Cash Flow	2.1B	627M	1.42B	2.82B	2.17B
Change In Net Working Capital	-249M	1.06B	504M	-854M	147M
Net Debt Issued / Repaid	-349M	-828M	-172M	-2.22B	-96M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	5.86	5.68	6.29	7.03	8.04
Return on Total Capital	7.84	7.4	8.17	9.02	10.19
Return On Equity %	41.34	22.56	25.92	57.83	27.02
Return on Common Equity	173.3	37.79	44.44	110.75	33.54
Margin Analysis
Gross Profit Margin %	37.3	36.76	37.98	39.72	41.37
SG&A Margin	2.11	2.15	2.03	2.02	1.92
EBITDA Margin %	17.54	17.35	17.81	19.53	21.75
EBITA Margin %	14.11	13.86	14.42	16.4	18.48
EBIT Margin %	13.15	12.96	13.57	15.57	17.7
Income From Continuing Operations Margin %	7.58	5.22	6.38	19.67	11.11
Net Income Margin %	4.69	2.14	2.97	15.49	6.6
Net Avail. For Common Margin %	4.7	2.14	2.97	15.49	6.6
Normalized Net Income Margin	3.15	2.89	3.11	4.25	5.29
Levered Free Cash Flow Margin	8	0.54	4.35	11.27	7.87
Unlevered Free Cash Flow Margin	10.79	3.27	6.93	13.64	10.17
Asset Turnover
Asset Turnover	0.71	0.7	0.74	0.72	0.73
Fixed Assets Turnover	2.57	2.55	2.76	2.87	2.93
Receivables Turnover (Average Receivables)	5.8	5.67	5.99	6.4	6.76
Inventory Turnover (Average Inventory)	32.49	30.74	31.23	32.91	36
Short Term Liquidity
Current Ratio	1.38	1.34	1.51	1.78	1.76
Quick Ratio	1.12	1.09	1.09	1.54	1.51
Operating Cash Flow to Current Liabilities	0.31	0.24	0.5	0.47	0.79
Days Sales Outstanding (Average Receivables)	62.92	64.42	60.98	57.19	53.96
Days Outstanding Inventory (Average Inventory)	11.23	11.87	11.69	11.12	10.14
Average Days Payable Outstanding	37.4	42.13	41.68	39.9	38.76
Cash Conversion Cycle (Average Days)	36.75	34.16	30.98	28.41	25.34
Long Term Solvency
Total Debt/Equity	393.96	354.43	294.35	167.63	160.79
Total Debt / Total Capital	79.76	77.99	74.64	62.63	61.66
LT Debt/Equity	386.07	346.79	288.47	164.16	157.53
Long-Term Debt / Total Capital	78.16	76.31	73.15	61.34	60.4
Total Liabilities / Total Assets	84.56	83.03	80.55	70.46	69.76
EBIT / Interest Expense	2.78	2.79	3.1	3.9	4.59
EBITDA / Interest Expense	4.15	4.2	4.52	5.39	6.14
(EBITDA - Capex) / Interest Expense	3.44	3.34	3.69	4.26	4.91
Total Debt / EBITDA	4.38	4.37	3.98	3.22	2.86
Net Debt / EBITDA	3.76	4.14	3.66	2.53	2.28
Total Debt / (EBITDA - Capex)	5.29	5.49	4.87	4.07	3.58
Net Debt / (EBITDA - Capex)	4.54	5.2	4.49	3.2	2.85
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	10.46	-1.6	7.17	0.57	3.07
Gross Profit, 1 Yr. Growth %	16.64	-3.03	10.74	5.18	7.28
EBITDA, 1 Yr. Growth %	40.85	-2.66	10.01	10.12	14.84
EBITA, 1 Yr. Growth %	57.96	-3.38	11.52	14.18	16.17
EBIT, 1 Yr. Growth %	63.29	-3.01	12.23	15.13	17.22
Earnings From Cont. Operations, 1 Yr. Growth %	92.32	-32.3	31.1	209.99	-41.76
Net Income, 1 Yr. Growth %	129.07	-55.03	48.66	423.73	-56.03
Normalized Net Income, 1 Yr. Growth %	535.7	-9.85	15.35	36.54	28.53
Diluted EPS Before Extra, 1 Yr. Growth %	124.8	-55.13	50.87	473.12	-52.63
Accounts Receivable, 1 Yr. Growth %	0.48	4.72	-1.68	-10.28	6.32
Inventory, 1 Yr. Growth %	4.35	5.47	1.48	-15.82	0.58
Net Property, Plant and Equip., 1 Yr. Growth %	-4.19	2.18	-3.58	-3.18	5.12
Total Assets, 1 Yr. Growth %	1.74	-1.53	4.26	2.2	2.56
Tangible Book Value, 1 Yr. Growth %	-6.26	6.94	-3.25	-21.36	5.17
Common Equity, 1 Yr. Growth %	3.57K	11.09	40.81	159.39	1.17
Cash From Operations, 1 Yr. Growth %	-53.98	-30.93	119.21	-13.77	72.94
Capital Expenditures, 1 Yr. Growth %	21.85	15.81	-1.44	23.97	8.49
Levered Free Cash Flow, 1 Yr. Growth %	1.74	-93.34	759.69	159.72	-27.98
Unlevered Free Cash Flow, 1 Yr. Growth %	-0.87	-70.18	127.09	97.44	-23.12
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	2.69	4.26	2.69	3.82	1.8
Gross Profit, 2 Yr. CAGR %	4.04	6.35	3.63	7.92	6.18
EBITDA, 2 Yr. CAGR %	8.57	17.09	3.48	10.16	12.3
EBITA, 2 Yr. CAGR %	10.87	23.54	3.8	12.95	14.97
EBIT, 2 Yr. CAGR %	11.82	25.85	4.34	13.8	15.96
Earnings From Cont. Operations, 2 Yr. CAGR %	203.83	14.11	-5.79	101.49	34.37
Net Income, 2 Yr. CAGR %	106.18	1.49	-18.24	179.03	51.75
Normalized Net Income, 2 Yr. CAGR %	25.26	139.39	1.97	25.79	31.83
Diluted EPS Before Extra, 2 Yr. CAGR %	96.2	0.43	-17.72	194.05	64.76
Accounts Receivable, 2 Yr. CAGR %	1.57	1.64	1.47	-6.08	-2.33
Inventory, 2 Yr. CAGR %	11.3	4.91	3.46	-7.57	-7.98
Net Property, Plant and Equip., 2 Yr. CAGR %	-2.34	-1.06	-0.74	-3.38	0.88
Total Assets, 2 Yr. CAGR %	8.64	0.09	1.32	3.23	2.38
Tangible Book Value, 2 Yr. CAGR %	2.45	0.12	1.72	-12.77	-9.06
Common Equity, 2 Yr. CAGR %	57.01	538.64	25.07	91.11	62
Cash From Operations, 2 Yr. CAGR %	12.77	-43.62	23.05	37.48	22.11
Capital Expenditures, 2 Yr. CAGR %	-0.9	18.79	6.83	10.53	15.97
Levered Free Cash Flow, 2 Yr. CAGR %	71.85	-73.97	-24.33	373.51	36.29
Unlevered Free Cash Flow, 2 Yr. CAGR %	37.74	-45.63	-17.71	112.03	22.94
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2.09	1.24	5.22	1.98	3.58
Gross Profit, 3 Yr. CAGR %	2.95	1.63	7.8	4.14	7.75
EBITDA, 3 Yr. CAGR %	6.97	4.69	14.68	5.71	11.7
EBITA, 3 Yr. CAGR %	8.13	5.9	19.39	7.22	14.01
EBIT, 3 Yr. CAGR %	8.79	6.64	21.14	7.9	14.93
Earnings From Cont. Operations, 3 Yr. CAGR %	47.96	84.2	19.51	40.13	33.23
Net Income, 3 Yr. CAGR %	106.37	24.11	15.26	51.85	50.71
Normalized Net Income, 3 Yr. CAGR %	19.29	12.25	87.68	12.61	26.7
Diluted EPS Before Extra, 3 Yr. CAGR %	105.6	19.98	15.02	57.14	59.99
Accounts Receivable, 3 Yr. CAGR %	2.87	1.98	0.52	-2.61	-2.11
Inventory, 3 Yr. CAGR %	7.98	9.32	3.75	-3.41	-4.93
Net Property, Plant and Equip., 3 Yr. CAGR %	2.04	-0.86	-1.91	-1.56	-0.63
Total Assets, 3 Yr. CAGR %	7.16	5.14	1.46	1.61	3
Tangible Book Value, 3 Yr. CAGR %	2.14	3.92	-1.02	-6.64	-7.16
Common Equity, 3 Yr. CAGR %	105.19	39.91	285.81	59.5	54.6
Cash From Operations, 3 Yr. CAGR %	14.34	-4.23	-11.35	9.29	48.41
Capital Expenditures, 3 Yr. CAGR %	2.17	4.38	11.62	12.26	9.85
Levered Free Cash Flow, 3 Yr. CAGR %	11.72	-41.84	-16.48	14.31	152.76
Unlevered Free Cash Flow, 3 Yr. CAGR %	7.34	-17.3	-12.44	10.26	51.19
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.14	-0.01	2.33	2.26	3.85
Gross Profit, 5 Yr. CAGR %	0.35	0.74	3.22	4.1	7.19
EBITDA, 5 Yr. CAGR %	5.92	5.57	5.56	6.84	13.82
EBITA, 5 Yr. CAGR %	8.08	7.65	6.38	8.67	17.73
EBIT, 5 Yr. CAGR %	8.38	8.33	6.98	9.45	19.18
Earnings From Cont. Operations, 5 Yr. CAGR %	52.17	25.59	23.52	90.97	25.25
Net Income, 5 Yr. CAGR %	36.62	-10.2	42.5	71.61	28.67
Normalized Net Income, 5 Yr. CAGR %	28.16	38.86	12.04	17.51	63.46
Diluted EPS Before Extra, 5 Yr. CAGR %	34.96	-11.58	42.53	71.72	32.8
Accounts Receivable, 5 Yr. CAGR %	-0.38	2.74	1.93	-1.32	-0.63
Inventory, 5 Yr. CAGR %	3.33	6.98	6.15	2.22	-1.11
Net Property, Plant and Equip., 5 Yr. CAGR %	-1.6	1.55	0.92	-1.88	-0.8
Total Assets, 5 Yr. CAGR %	2.23	3.04	4.79	4.37	1.83
Tangible Book Value, 5 Yr. CAGR %	1.91	3.1	1.97	-3.11	-4.31
Common Equity, 5 Yr. CAGR %	19.78	50.68	68.32	58.5	172.67
Cash From Operations, 5 Yr. CAGR %	22.95	-2.03	17.74	10.67	0.77
Capital Expenditures, 5 Yr. CAGR %	-5.54	1.51	4.01	6.8	13.34
Levered Free Cash Flow, 5 Yr. CAGR %	26.64	-29.27	-4.4	34.56	1.82
Unlevered Free Cash Flow, 5 Yr. CAGR %	14.91	-11.95	-3.49	20.52	0.43